Cost-effectiveness of self-expandable transcatheter aortic valves in intermediate-risk patients

DY Tam, A Hughes, HC Wijeysundera… - The Annals of thoracic …, 2018 - Elsevier
Background A recent clinical trial showed that self-expandable transcatheter aortic valve
replacement (TAVR) was non-inferior to surgical aortic valve replacement (SAVR). However …
被引用次数：44 相关文章

Cost-Effectiveness of Self-Expandable Transcatheter Aortic Valves in Intermediate-Risk Patients.

DY Tam, A Hughes, HC Wijeysundera… - The Annals of Thoracic …, 2018 - europepmc.org
Background A recent clinical trial showed that self-expandable transcatheter aortic valve
replacement (TAVR) was non-inferior to surgical aortic valve replacement (SAVR). However …

Cost-Effectiveness of Self-Expandable Transcatheter Aortic Valves in Intermediate-Risk Patients

DY Tam, A Hughes, HC Wijeysundera, SE Fremes - 2018 - pubmed.ncbi.nlm.nih.gov
Background A recent clinical trial showed that self-expandable transcatheter aortic valve
replacement (TAVR) was non-inferior to surgical aortic valve replacement (SAVR). However …

Cost-Effectiveness of Self-Expandable Transcatheter Aortic Valves in Intermediate-Risk Patients

DY Tam, A Hughes… - The Annals of …, 2018 - annalsthoracicsurgery.org
Background A recent clinical trial showed that self-expandable transcatheter aortic valve
replacement (TAVR) was non-inferior to surgical aortic valve replacement (SAVR). However …